MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings ROA Ratio 2011-2026 | MEDP
Annual ROA Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.25 | 17.07 | 18.14 | 10.96 | 10.45 | 8.79 | 7.56 | 4.11 | 1.37 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.25 | 1.37 | 10.86 |
Quarterly ROA Ratio Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.75 | 21.04 | 19.89 | 14.94 | 19.69 | 19.81 | 19.54 | 14.31 | 19.28 | 19.5 | 19.72 | 14.09 | 17.17 | 10.72 | 13.44 | 8.78 | 11.76 | 11.66 | 10.68 | 6.8 | 9.4 | 8.52 | 9.19 | 8.79 | 8.53 | 8.43 | 7.74 | 7.56 | 6.4 | 5.44 | 4.73 | 4.11 | 2.93 | 2.41 | 1.91 | 1.37 | 0.5 | -0.03 | -0.53 | -0.89 | -0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.75 | -0.89 | 10.05 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
DexCom
DXCM
|
8.64 | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.12 | - | $ 99.5 K | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
-29.37 | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 250.88 | -0.87 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.22 | -0.43 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 676.53 | -0.85 % | $ 55.8 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.55 | -0.91 % | $ 4.61 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 394.19 | -1.42 % | $ 29.6 B |  Schweiz |
 |
Precipio
PRPO
|
-32.34 | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Agilent Technologies
A
|
11.3 | $ 136.07 | -1.13 % | $ 41.4 B | USA |
 |
Personalis
PSNL
|
-30.08 | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.52 | 2.86 % | $ 5.79 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.44 | -0.13 % | $ 466 M | USA |